{
    "2020-11-29": [
        [
            {
                "time": "",
                "original_text": "甘李药业自主研发抗癌药临床试验申请受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "抗癌药",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "250亿市场，这20个药卖得最好",
                "features": {
                    "keywords": [
                        "250亿市场",
                        "畅销药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业（603087.SH）：拟用于多种晚期实体肿瘤治疗的GLR2007临床试验申请受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GLR2007",
                        "晚期实体肿瘤",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：硬胶囊剂的临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "硬胶囊剂",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：药品GLR2007的临床试验申请获得国家药监局受理",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GLR2007",
                        "临床试验",
                        "国家药监局",
                        "申请受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}